Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration

Circulation Research

Volumn 86, Issue 1, 2000, Pages 15-23

  Duan, Cunming ^a   Bauchat, Jeanette R ^a   Hsieh, Tzefu ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Insulin like growth factor I; Migration; Phosphatidylinositol 3 kinase; Proliferation; Vascular smooth muscle cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0033972216     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.1.15     Document Type: Article

References (47)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Clemmons DR. Growth factors and atherosclerosis. Diabetes Rev. 1997; 5:353-364.
3. Wang JW, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, Fagin JA. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest. 1997;100:1425-1439.
4. Banskota NK, Taub R, Zellner K, Olsen P, King G. Characterization of induction of proto-oncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes. 1989;38:123-129.
5. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 1994;93:1266-1274.
6. Gockerman A, Prevette T, Jones JI, Clemmons DR. Insulin-like growth factor binding prolein-2 inhibits smooth muscle cell migration response to IGF-I. Endocrinology. 1995;136:4168-4173.
7. Du J, Delafontaine P. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA. Circ Res. 1995;76:963-972.
8. Delafontaine P, Meng XP, Ku L, Du J. Regulation of vascular smooth muscle cell insulin-like growth factor I receptor by phosphorothioate oligonucleotides. J Biol Chem. 1995;270:14383-14388.
9. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol Rev. 1995;16:143-163.
10. White MF. The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem. 1998;182:3-11.
11. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R. Platelet-derived growth factor: distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci. 1995;66: 416-430.
12. Takagi Y, Kashiwagi A, Tanaka Y, Maegawa H, Shigeta Y. Insulin-specific activation of S6 kinase and IRS desensitization in cultured rat vascular smooth muscle cells. Atherosclerosis. 1995;13:19-27.
13. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines FW, Ross R, Leslie CC, Krebs EG. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem. 1996;272:505-511.
14. Koyama H, Nishizawa Y, Hosoi M, Kogawa K, Shioi A, Morii H. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor, I: possible involvement of cyclin-dependent kinase 2. Circ Res. 1996;9:757-764.
15. Thommes KB, Hoppe J, Vetter H, Sachinidis A. The synergistic effect of PDGF-AA and IGF-I on SMC proliferation might be explained by the differential activation of their intracellular signaling pathways. Exp Cell Res. 1996;26:59-66.
16. Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T. Roles of insulin receptor substrate-1 and she on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Endocrinology. 1997;38:741-750.
17. Milansincic DJ, Calera MR, Farmer SR, Pilch PF. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol. 1996;6:5964-5973.
18. Folli F, Kahn CR, Hansen H, Bouchie JL, Feenet EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. J Clin Invest. 1997;100:2158-2169.
19. Duan C, Hawes SB, Prevette T, Clemmons DR. Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem. 1996;272:4280-4288.
20. Yano K, Bauchat JR, Liimatta M, Clemmons DR, Duan C. Down-regulation of protein kinase C inhibits IGF-I-induced vascular smooth muscle cell proliferation, migration and gene expression. Endocrinology. 1999;140:4622-4632.
21. Duan C, Clemmons DR. Differential expression and opposing biological effects of insulin-like growth factor binding protein-4 and -5 in vascular smooth muscle cells. J Biol Chem. 1998;273:16836-16842.
22. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Williams LT, Zetter BR. Regulation of chemotaxis by the platelet-derived growth factor-B. Nature. 1994;367:474-476.
23. Bayne ML, Applebaum J, Chicchi GG, Miller RE, Cascieri MA. The roles of tyrosine-24, tyrosine-31, and tyrosine-60 in the high affinity binding of insulin-like growth factor-I to the type-1 insulin-like growth factor. J Biol Chem. 1990;265:15648-15652.
24. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990;61:203-212.
25. Kimura K, Hattori S, Kabuyama Y, Sgizawa Y, Takayanagi J, Nakamura S, Toki S, Matsuda Y, Onodera K, Fukui Y. Neunte outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidyl-inositol 3-kinase. J Biol Chem. 1994;269:18961-18967.
26. Clemmons DR, Van Wyk J. Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J Clin Invest. 1985;75:1914-1918.
27. Dufourny B, Alblast J, van Teeffelen AAM, van Schaik FMA, van der Burg B, Steenbergh PH, Sussenbach JS. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem. 1997;272:31163-31171.
28. Stephens L, Eguinoa A, Corey S, Jackson T, Hawkins PT. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. EMBO J. 1995;12:2265-2273.
29. Kundra V, Anand-Apte B, Feig LA, Zetter BR. The chemotactic response to PDGF-BB: evidence of a role for Ras. J Cell Biol. 1995;130:725-731.
30. Clyman RI, Peters KG, Chen YQ, Escobedo J, Williams LT, Ives HE, Wilson E. Phospholipase C gamma activation, phosphotidylinisitol hydrolysis, and calcium mobilization are not required for FGF receptor-mediated chemotaxis. Cell Adhes Commun. 1994;1:333-342.
31. Derman MP, Cunha MJ, Barros EJG, Nigam SK, Cantley LG. HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. Am J Physiol. 1995;37:F1211-F1217.
32. Bilato C, Pauly RR, Melillo G, Monticone R, Gorelick-Feldman D, Gluzband YA, Sollott SJ, Ziman B, Lakatta EG, Crow MT. Intracellular signaling pathways required for rat vascular smooth muscle cell migration: interactions between basic fibroblasts growth factor and platelet-derived growth factor. J Clin Invest. 1995;96:1905-1915.
33. Graf K, Xi X, Yang D, Fleck E, Hsueh W, Kent K. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 1996; 29:334-339.
34. Pukac L, Huangpu J, Karnovsky M. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res. 1998;242:548-560.
35. Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K. Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J Biol Chem. 1996;271: 29342-29346.
36. Marte BM, Downward J. PKB/Akf. connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci. 1997;22:355-358.
37. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase akt. Science. 1997;275:661-664.
38. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 1997;275:665-667.
39. Meili R, Ellsworth C, Lee S, Reddy TBK, Ma H, Firtel RA. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J. 1999;18:2092-2105.
40. Parent CA, Devreotes PN. A cell's sense of direction. Science. 1999;284: 765-770.
41. s6k activity. Oncogenes. 1996;13:343-351.
42. Poon M, Marx S, Gallo R, Badimon J, Tauman M, Marks A. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest. 1996;98: 2277-2283.
43. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein Rac regulates growth-factor induced membrane ruffling. Cell. 1992;70:401-410.
44. Zhang J, King WG, Dillion S, Hall A, Feig L, Rittenhouse SE. Activation of platelet phosphatidylinositide 3-kinase requires the small GTP-binding protein Rho. J Biol Chem. 1993;268:22251-22254.
45. Liscovitch M, Cantley LC. Lipid second messengers. Cell. 1994;77: 329-334.
46. Moriya S, Kazlauskas A, Akimoto K, Hirai S, Mizuno K, Takenawa T, Fukui Y, Watanabe Y, Ozaki S, Ohno S. Platelet-derived growth factor activates protein kinase Ce through redundant and independent signaling pathways involving phospholipase Cγ or phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 1996;93:151-155.
47. Liu Q, Ning W, Danger R, Freund GG, Kelley KW. Activation of protein kinase Cζ and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J Immunol. 1998; 160:1393-1401.